−0.169409 USD
−132.89 M USD
0.00 USD
276.17 M
About HIGHTIDE THERAPEUTICS INC.
Sector
Industry
CEO
Li Ping Liu
Website
Headquarters
Shenzhen
Founded
2011
FIGI
BBG01MBDM497
Hightide Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for people suffering from non-viral chronic liver diseases, gastrointestinal diseases, and metabolic disorders with large and unsatisfied market needs. The company was founded by Li Ping Liu in 2011 and is headquartered in Shenzhen, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange HIGHTIDE THERAPEUTICS INC stocks are traded under the ticker HTTIF.
Yes, you can track HIGHTIDE THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
HTTIF net income for the last half-year is −29.27 M USD, while the previous report showed −53.88 M USD of net income which accounts for 45.69% change. Track more HIGHTIDE THERAPEUTICS INC financial stats to get the full picture.
No, HTTIF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Mar 13, 2025, the company has 66.00 employees. See our rating of the largest employees — is HIGHTIDE THERAPEUTICS INC on this list?
Like other stocks, HTTIF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HIGHTIDE THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.